Stock listing
Frankfurt:7R8 Replimune Group, Inc. Aktie
German listing (Frankfurt) of Replimune Group, Inc. · home listing NASDAQ:REPL
Follow Replimune Group, Inc. into a list and get an email when it puts out news.
Share price · FWB:7R8
€17.03 EUR -0.61 (-3.5%)
Close on Nov 20, 2026
- Day range
- €17.03 – €17.47 EURNov 20, 2026
- Market cap
- €1.60B EURAt the close on Nov 20, 2026 · price × 94.22M shares outstanding
- 52-week range
- €1.43 – €19.80 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €9,559 EURMedian day 0 shares · 38 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:REPL · Home | $19.07 USD | -0.74 (-3.7%) | 1,964,115 | $18.80 | $19.50 | $18.70 | $19.81 | Close on Nov 20, 2026 |
| Frankfurt:7R8 | €17.03 EUR | -0.61 (-3.5%) | — | €17.12 | €17.47 | €17.03 | €17.64 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:7R8 · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €19.80 | +1.802 | +10.0% | €17.45 | €19.80 | €17.41 | 10 | |
| €17.99 | +0.178 | +1.0% | €17.99 | €17.99 | €17.99 | 842 | |
| €17.82 | +0.792 | +4.7% | €17.96 | €18.06 | €17.82 | 200 | |
| €17.02 | +1.677 | +10.9% | €17.13 | €17.19 | €17.02 | 500 | |
| €15.35 | +0.42 | +2.8% | €16.03 | €16.12 | €15.26 | 200 | |
| €14.93 | -0.968 | -6.1% | €15.24 | €15.94 | €14.92 | 200 | |
| €15.89 | +4.205 | +36.0% | €15.20 | €15.96 | €14.95 | 17,868 | |
| €11.69 | +0.565 | +5.1% | €11.56 | €11.69 | €11.44 | 17,390 | |
| €11.12 | +0.527 | +5.0% | €10.95 | €11.24 | €10.92 | 0 | |
| €10.60 | +0.214 | +2.1% | €10.08 | €10.61 | €9.987 | 554 | |
| €10.38 | +0.267 | +2.6% | €10.42 | €10.52 | €10.34 | 0 | |
| €10.12 | +0.288 | +2.9% | €10.12 | €10.20 | €10.07 | 0 | |
| €9.828 | +0.175 | +1.8% | €9.85 | €9.868 | €9.812 | 0 | |
| €9.653 | +0.285 | +3.0% | €9.718 | €9.718 | €9.634 | 0 | |
| €9.368 | -0.934 | -9.1% | €9.423 | €9.467 | €9.309 | 0 | |
| €10.30 | +0.527 | +5.4% | €10.30 | €10.31 | €10.21 | 0 | |
| €9.775 | -0.68 | -6.5% | €9.958 | €10.08 | €9.772 | 350 | |
| €10.46 | -0.986 | -8.6% | €10.51 | €10.83 | €10.43 | 100 | |
| €11.44 | -0.072 | -0.6% | €11.45 | €11.45 | €11.38 | 0 | |
| €11.51 | +0.128 | +1.1% | €11.63 | €11.96 | €11.46 | 100 | |
| €11.39 | -0.066 | -0.6% | €11.41 | €11.44 | €11.39 | 0 | |
| €11.45 | -0.406 | -3.4% | €11.47 | €11.47 | €11.34 | 0 | |
| €11.86 | +0.333 | +2.9% | €11.50 | €11.86 | €11.50 | 150 | |
| €11.52 | +0.093 | +0.8% | €11.52 | €11.52 | €11.52 | 0 | |
| €11.43 | -0.354 | -3.0% | €11.46 | €11.46 | €11.40 | 320 | |
| €11.79 | +0.264 | +2.3% | €11.79 | €11.79 | €11.74 | 0 | |
| €11.52 | +0.285 | +2.5% | €11.54 | €11.58 | €11.52 | 0 | |
| €11.24 | +0.402 | +3.7% | €11.30 | €11.34 | €11.18 | 0 | |
| €10.83 | +0.25 | +2.4% | €10.64 | €10.87 | €10.58 | 0 | |
| €10.58 | -0.288 | -2.6% | €10.55 | €10.62 | €10.49 | 0 | |
| €10.87 | +0.329 | +3.1% | €10.89 | €10.90 | €10.77 | 0 | |
| €10.54 | -0.961 | -8.4% | €11.03 | €11.04 | €10.44 | 77 | |
| €11.50 | +0.615 | +5.6% | €11.51 | €11.55 | €11.42 | 0 | |
| €10.89 | -0.23 | -2.1% | €10.92 | €10.92 | €10.85 | 0 | |
| €11.12 | +0.106 | +1.0% | €11.04 | €11.24 | €10.95 | 0 | |
| €11.01 | -0.103 | -0.9% | €11.01 | €11.06 | €11.00 | 0 | |
| €11.12 | +0.096 | +0.9% | €11.14 | €11.16 | €11.11 | 0 | |
| €11.02 | -0.028 | -0.3% | €11.07 | €11.11 | €10.99 | 0 | |
| €11.05 | +0.173 | +1.6% | €11.04 | €11.09 | €10.95 | 0 | |
| €10.88 | -0.392 | -3.5% | €10.88 | €10.88 | €10.87 | 0 | |
| €11.27 | -0.909 | -7.5% | €11.33 | €11.35 | €11.24 | 0 | |
| €12.18 | -0.11 | -0.9% | €12.23 | €12.29 | €12.18 | 0 | |
| €12.29 | -0.207 | -1.7% | €12.41 | €12.44 | €12.23 | 0 | |
| €12.49 | +0.013 | +0.1% | €12.51 | €12.51 | €12.47 | 0 | |
| €12.48 | -0.383 | -3.0% | €12.51 | €12.51 | €12.48 | 0 | |
| €12.86 | -0.413 | -3.1% | €12.91 | €12.91 | €12.80 | 0 | |
| €13.28 | +0.071 | +0.5% | €13.37 | €13.43 | €13.17 | 0 | |
| €13.21 | +0.423 | +3.3% | €13.31 | €13.94 | €13.12 | 100 | |
| €12.78 | -0.169 | -1.3% | €12.79 | €12.80 | €12.73 | 0 | |
| €12.95 | -0.16 | -1.2% | €13.01 | €13.02 | €12.87 | 0 | |
| €13.11 | -0.257 | -1.9% | €13.13 | €13.17 | €13.09 | 0 | |
| €13.37 | +0.163 | +1.2% | €13.37 | €13.37 | €13.37 | 0 | |
| €13.21 | +0.85 | +6.9% | €13.21 | €13.23 | €13.16 | 250 | |
| €12.36 | -0.40 | -3.1% | €12.37 | €12.95 | €12.33 | 40 | |
| €12.76 | +0.933 | +7.9% | €12.41 | €12.88 | €12.40 | 100 | |
| €11.82 | -0.537 | -4.3% | €11.87 | €11.87 | €11.80 | 0 | |
| €12.36 | -0.296 | -2.3% | €12.24 | €12.43 | €12.21 | 0 |
- Ticker
- Frankfurt:7R8
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 28, 2026
Replimune Reports Fiscal Second Quarter 2027 Financial Results and Provides Corporate Update
Latest earnings call · Oct 28, 2026
Replimune Group (NASDAQ:REPL) Q2 2027 Earnings Call
Replay and transcript
Latest deck · Aug 6, 2026
Corporate Update (August 2026)
Corporate update · 30 slides
Calls
Replays
Replimune Group (NASDAQ:REPL) Q2 2027 Earnings Call
Wed, Oct 28, 2026 · 8:00 AM ET
Watch TranscriptReplimune Group (NASDAQ:REPL) Q4 2025 Earnings Call
Thu, May 22, 2025 · 8:00 AM ET
Watch Transcript
Latest news
Replimune Reports Fiscal Second Quarter 2027 Financial Results and Provides Corporate Update
Oct 28, 2026
Closed €11.69 (+5.1%) on Oct 28, 2026
Replimune to Report the Fiscal Second Quarter 2027 Financial Results and Provide Corporate Update on October 28, 2026
Oct 22, 2026
Closed €10.12 (+2.9%) on Oct 22, 2026
Replimune Announces TUDRIQEV™ Now Available in the U.S. for Advanced Melanoma
Oct 1, 2026
Closed €11.79 (+2.3%) on Oct 2, 2026
Replimune to Present at the Cantor Global Healthcare Conference 2026
Sep 3, 2026
Closed €13.28 (+0.5%) on Sep 3, 2026
Replimune Reports Fiscal First Quarter 2027 Financial Results and Provides Corporate Update
Aug 14, 2026
Closed €13.28 (+3.9%) on Aug 14, 2026
Replimune Announces Pricing of $150 Million Underwritten Offering
Aug 10, 2026
Closed €10.60 (-2.8%) on Aug 10, 2026
Replimune Announces FDA Accelerated Approval of TUDRIQEVTM in Combination with Nivolumab for Unresectable Advanced Cutaneous Melanoma After Progression on an anti-PD-1 Based Regimen
Aug 6, 2026
Closed €10.90 (+7.1%) on Aug 7, 2026
Replimune Announces Favorable Outcome of FDA's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma
Jul 30, 2026
Closed €4.59 (-0.5%) on Jul 31, 2026
Replimune Reports Fiscal Fourth Quarter and Year End 2026 Financial Results and Provides Corporate Update
Jun 29, 2026
Closed €9.79 (+14.3%) on Jun 29, 2026
Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma
Jun 26, 2026
Closed €8.57 (-10.3%) on Jun 26, 2026
Financings
Public offering of common stock
Aug 14, 2026
Closed: US$150M raised · US$12.06 a share · Leerink Partners +2
Dealers: Leerink Partners (co-lead), J.P. Morgan (co-lead), Cantor (co-lead)
Use of proceeds: Support the commercial launch of TUDRIQEV and the ongoing IGNYTE-3 confirmatory trial
Public offering of common stock and pre-funded warrants
Nov 25, 2024
Announced: about US$140M · US$13 a share · Leerink Partners
Dealers: Leerink Partners (lead)
Public offering of common stock and pre-funded warrants
Nov 25, 2024
Announced: US$125M · Leerink Partners
Dealers: Leerink Partners (lead)
Decks
Corporate Update (August 2026)
Corporate update · 30 slides · Aug 6, 2026
Technical Presentation (July 2026)
Technical · 64 slides · Jul 30, 2026
JPM Healthcare Conference 2026
Conference · 30 slides · Jan 14, 2026
Technical Presentation (June 2024)
Technical · 27 slides · Jun 6, 2024
Replimune Group, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 16 in the last 12 months · 139 in all · newest Oct 28, 2026 · oldest 2019
- Calls
- 2 calls with a replay · 2 with a transcript · latest Oct 28, 2026
- Decks
- 9 decks · latest Aug 6, 2026
Where Replimune Group, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:REPL · Home listing | NASDAQ | United States | USD |
| gettex:7R8 | gettex | Germany | EUR |
| LS Exchange:A2JQN1 | LS Exchange | Germany | EUR |
| BOATS:REPL | BOATS | United States | USD |
| Lang & Schwarz:A2JQN1 | Lang & Schwarz | Germany | EUR |
| Stuttgart:7R8 | Stuttgart | Germany | EUR |
| Tradegate:7R8 | Tradegate | Germany | EUR |
| Frankfurt:7R8 · This page | Frankfurt | Germany | EUR |
| Hamburg:7R8 | Hamburg | Germany | EUR |
| Munich:7R8 | Munich | Germany | EUR |
| Dusseldorf:7R8 | Dusseldorf | Germany | EUR |
Log in to ask 6ix AI your own questions about Replimune Group, Inc.